{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:03:26Z","timestamp":1792029806422,"version":"4.4.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche Medicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"Universit\u00e9 Paris Cit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.kint.2025.07.037","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:36:54Z","timestamp":1758760614000},"page":"1057-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis"],"prefix":"10.1016","volume":"108","author":[{"given":"H\u00e9l\u00e8ne","family":"Lazareth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8107-6987","authenticated-orcid":false,"given":"Olivia","family":"Lenoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Garo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Giscos-Douriez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasreddine","family":"Saidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Guyonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"H\u00e9nique-Gr\u00e9ciet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5449-9191","authenticated-orcid":false,"given":"Maria-Christina","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheerazed","family":"Boulkroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-5905","authenticated-orcid":false,"given":"Pierre-Louis","family":"Tharaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.07.037_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1523-1755.2004.00831.x","article-title":"The Italian experience of the national registry of renal biopsies","volume":"66","author":"Gesualdo","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/ndt\/17.9.1594","article-title":"Frequency of renal pathology in Spain 1994\u20131999","volume":"17","author":"Rivera","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.07.037_bib3","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1093\/ndt\/gfl237","article-title":"Paulista Registry of glomerulonephritis: 5-year data report","volume":"21","author":"Malafronte","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.07.037_bib4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.34067\/KID.0005882022","article-title":"The Cleveland Clinic Kidney Biopsy Epidemiological Project","volume":"3","author":"Bobart","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.kint.2025.07.037_bib5","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.4103\/1319-2442.374379","article-title":"Glomerular diseases in the Colombian Caribbean: data from the colombian nephropathy registry (NEFRORED(R))","volume":"33","author":"Aroca-Martinez","year":"2022","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.kint.2025.07.037_bib6","first-page":"546","article-title":"Disease spectrum of 9 310 cases of renal biopsy pathological diagnosis from a single center in China","volume":"47","author":"Huang","year":"2022","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.kint.2025.07.037_bib7","first-page":"11","article-title":"Kidney disease patterns diagnosed by kidney biopsy: a single-center experience from central India","volume":"70","author":"Banode","year":"2022","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.kint.2025.07.037_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/j.ajkd.2016.03.416","article-title":"Distribution of biopsy-proven presumed primary glomerulonephropathies in 2000\u20132011 among a racially and ethnically diverse US population","volume":"68","author":"Sim","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.07.037_bib9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.mayocp.2017.09.011","article-title":"The incidence of primary vs secondary focal segmental glomerulosclerosis: a clinicopathologic study","volume":"92","author":"Hommos","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.kint.2025.07.037_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1523-1755.2001.060003957.x","article-title":"Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat","volume":"60","author":"Kim","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib12","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1681\/ASN.2005010055","article-title":"Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene","volume":"16","author":"Wharram","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib13","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.2215\/CJN.10571011","article-title":"Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant","volume":"7","author":"Fatima","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrneph.2014.1","article-title":"The emergence of the glomerular parietal epithelial cell","volume":"10","author":"Shankland","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib15","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1016\/j.ajpath.2014.08.007","article-title":"Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease","volume":"184","author":"Smeets","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2025.07.037_bib16","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41467-019-11013-2","article-title":"The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression","volume":"10","author":"Lazareth","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.07.037_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.kint.2019.04.038","article-title":"Cellular regeneration of podocytes from parietal cells: the debate is still open","volume":"96","author":"Moeller","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ekir.2022.10.004","article-title":"Novel treatment paradigms: focal segmental glomerulosclerosis","volume":"8","author":"de Cos","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.07.037_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000517108","article-title":"Mechanisms of scarring in focal segmental glomerulosclerosis","volume":"7","author":"Sun","year":"2021","journal-title":"Kidney Dis (Basel)"},{"key":"10.1016\/j.kint.2025.07.037_bib20","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1681\/ASN.2010090970","article-title":"Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis","volume":"22","author":"Smeets","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib21","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1681\/ASN.2009010122","article-title":"Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells","volume":"20","author":"Smeets","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00441-021-03513-9","article-title":"Parietal epithelial cell dysfunction in crescentic glomerulonephritis","volume":"385","author":"Wong","year":"2021","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.kint.2025.07.037_bib23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1681\/ASN.0000000000000104","article-title":"Podocyte-parietal epithelial cell interdependence in glomerular development and disease","volume":"34","author":"Bronstein","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MNH.0000000000000600","article-title":"Parietal epithelial cells role in repair versus scarring after glomerular injury","volume":"29","author":"Lazareth","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2025.07.037_bib25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/j.ajkd.2022.04.016","article-title":"Aldosterone, mineralocorticoid receptor activation, and CKD: a review of evolving treatment paradigms","volume":"80","author":"Epstein","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.07.037_bib26","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.3390\/ijms24097719","article-title":"Mineralocorticoid receptor antagonists for preventing chronic kidney disease progression: current evidence and future challenges","volume":"24","author":"Fujii","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.kint.2025.07.037_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0033-0620(74)90037-1","article-title":"Renin and aldosterone and the pathogenesis of hypertensive vascular damage","volume":"17","author":"Gavras","year":"1974","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.kint.2025.07.037_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/endo-38-5-315","article-title":"Influence of adrenal cortical steroids upon the blood pressure and the rate of progression of experimental nephritis in rats","volume":"38","author":"Knowlton","year":"1946","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2025.07.037_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/169795a0","article-title":"Isolation of a highly active mineralocorticoid from beef adrenal extract","volume":"169","author":"Grundy","year":"1952","journal-title":"Nature"},{"key":"10.1016\/j.kint.2025.07.037_bib30","first-page":"515","article-title":"Production of nephrosclerosis by overdosage with desoxycorticosterone acetate","volume":"47","author":"Selye","year":"1942","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.kint.2025.07.037_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00230355","article-title":"Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat","volume":"425","author":"Kretzler","year":"1994","journal-title":"Virchows Arch"},{"key":"10.1016\/j.kint.2025.07.037_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.1989.234","article-title":"Renal injury in DOCA-salt hypertensive C5-sufficient and C5-deficient mice","volume":"36","author":"Raij","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib33","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/labinvest.2015.118","article-title":"The roles of oxidative stress, endoplasmic reticulum stress, and autophagy in aldosterone\/mineralocorticoid receptor-induced podocyte injury","volume":"95","author":"Yuan","year":"2015","journal-title":"Lab Invest"},{"key":"10.1016\/j.kint.2025.07.037_bib34","doi-asserted-by":"crossref","first-page":"F556","DOI":"10.1152\/ajprenal.00332.2016","article-title":"NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury","volume":"312","author":"Bai","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.07.037_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160086","article-title":"Spironolactone promotes autophagy via inhibiting PI3K\/AKT\/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress","volume":"36","author":"Li","year":"2016","journal-title":"Biosci Rep"},{"key":"10.1016\/j.kint.2025.07.037_bib36","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1159\/000228080","article-title":"Aldosterone induces apoptosis in rat podocytes: role of PI3-K\/Akt and p38MAPK signaling pathways","volume":"113","author":"Chen","year":"2009","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib37","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2025.07.037_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","article-title":"Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker","volume":"47","author":"Nagase","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2025.07.037_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000334961","article-title":"Mineralocorticoid receptor blocker protects against podocyte-dependent glomerulosclerosis","volume":"2","author":"Takagi","year":"2012","journal-title":"Nephron Extra"},{"key":"10.1016\/j.kint.2025.07.037_bib40","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1093\/ndt\/gfp371","article-title":"Increased renoprotection with ACE inhibitor plus aldosterone antagonist as compared to monotherapies\u2014the effect on podocytes","volume":"24","author":"Nemeth","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.07.037_bib41","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2008070795","article-title":"Recruitment of podocytes from glomerular parietal epithelial cells","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1046\/j.1523-1755.2000.00965.x","article-title":"Mineralocorticoid receptor knockout mice: lessons on Na+ metabolism","volume":"57","author":"Berger","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib43","article-title":"Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.kint.2025.07.037_bib44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1681\/ASN.2014111080","article-title":"Nuclear factor erythroid 2-related factor 2 drives podocyte-specific expression of peroxisome proliferator-activated receptor gamma essential for resistance to crescentic GN","volume":"27","author":"Henique","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib45","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.2491","article-title":"Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis","volume":"17","author":"Bollee","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.07.037_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-74934-z","article-title":"Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease","volume":"14","author":"Soulie","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2025.07.037_bib47","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1291\/hypres.31.1251","article-title":"The specific mineralocorticoid receptor blocker eplerenone attenuates left ventricular remodeling in mice lacking the gene encoding guanylyl cyclase-A","volume":"31","author":"Zhang","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.kint.2025.07.037_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jss.2013.05.002","article-title":"Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model","volume":"185","author":"Kurobe","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.kint.2025.07.037_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist (SARA)","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.kint.2025.07.037_bib50","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41467-021-22368-w","article-title":"Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney","volume":"12","author":"Muto","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.07.037_bib51","doi-asserted-by":"crossref","first-page":"19619","DOI":"10.1073\/pnas.1908706116","article-title":"The single-cell transcriptomic landscape of early human diabetic nephropathy","volume":"116","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2025.07.037_bib52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.kint.2016.10.015","article-title":"Activated ERK1\/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion","volume":"91","author":"Roeder","year":"2017","journal-title":"Kidney Int"},{"issue":"4S","key":"10.1016\/j.kint.2025.07.037_bib53","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41581-021-00427-1","article-title":"Therapeutic trials in adult FSGS: lessons learned and the road forward","volume":"17","author":"De Vriese","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib55","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1681\/ASN.2013020195","article-title":"Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis","volume":"25","author":"Lenoir","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib56","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa2308550","article-title":"Sparsentan versus irbesartan in focal segmental glomerulosclerosis","volume":"389","author":"Rheault","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.07.037_bib57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.07.037_bib58","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/ckj\/sfad122","article-title":"Rituximab in the treatment of primary FSGS: time for its use in routine clinical practice?","volume":"16","author":"Morris","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.07.037_bib59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/MNH.0b013e32835fefd4","article-title":"Glomerular parietal epithelial cells in kidney physiology, pathology, and repair","volume":"22","author":"Shankland","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2025.07.037_bib60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/path.2051","article-title":"Lessons from studies on focal segmental glomerulosclerosis: an important role for parietal epithelial cells?","volume":"210","author":"Smeets","year":"2006","journal-title":"J Pathol"},{"issue":"5S","key":"10.1016\/j.kint.2025.07.037_bib61","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.07.037_bib62","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2337\/dc23-S011","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.07.037_bib63","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1056\/NEJM200109203451215","article-title":"Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease","volume":"345","author":"Chrysostomou","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.07.037_bib64","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1681\/ASN.2022020207","article-title":"Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial","volume":"33","author":"Provenzano","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib65","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6683987","article-title":"Efficacy and safety of eplerenone for treating chronic kidney disease: a meta-analysis","volume":"2023","author":"Hu","year":"2023","journal-title":"Int J Hypertens"},{"key":"10.1016\/j.kint.2025.07.037_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14557","article-title":"Long-term effect of eplerenone treatment in children with chronic allograft nephropathy","volume":"27","author":"Baskin","year":"2023","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.kint.2025.07.037_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfad249","article-title":"Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial","volume":"17","author":"Marup","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.07.037_bib68","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.3390\/biomedicines11123340","article-title":"A prospective study of eplerenone in the treatment of patients with glomerulonephritis","volume":"11","author":"Papasotiriou","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.kint.2025.07.037_bib69","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/HYPERTENSIONAHA.121.18360","article-title":"Mineralocorticoid receptor antagonist use and hard renal outcomes in real-world patients with chronic kidney disease","volume":"79","author":"Oka","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2025.07.037_bib70","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ekir.2021.12.013","article-title":"The kidney protective effects of the sodium-glucose cotransporter-2 inhibitor, dapagliflozin, are present in patients with CKD treated with mineralocorticoid receptor antagonists","volume":"7","author":"Provenzano","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.07.037_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1681\/ASN.2020071041","article-title":"The mineralocorticoid receptor in salt-sensitive hypertension and renal injury","volume":"32","author":"Ayuzawa","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.07.037_bib72","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.07.037_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kisu.2021.11.004","article-title":"Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease","volume":"12","author":"Nakamura","year":"2022","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.kint.2025.07.037_bib74","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/HYPERTENSIONAHA.110.160895","article-title":"Mineralocorticoid and epidermal growth factor receptors: partners in vivo","volume":"57","author":"Rickard","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2025.07.037_bib75","doi-asserted-by":"crossref","first-page":"T107","DOI":"10.1530\/JOE-16-0659","article-title":"30 Years of the mineralocorticoid receptor: nongenomic effects via the mineralocorticoid receptor","volume":"234","author":"Ruhs","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/j.kint.2025.07.037_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92284-y","article-title":"The mineralocorticoid receptor leads to increased expression of EGFR and T-type calcium channels that support HL-1 cell hypertrophy","volume":"11","author":"Stroedecke","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2025.07.037_bib77","doi-asserted-by":"crossref","first-page":"43060","DOI":"10.1074\/jbc.M308134200","article-title":"Aldosterone stimulates epidermal growth factor receptor expression","volume":"278","author":"Krug","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.kint.2025.07.037_bib78","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.steroids.2014.05.017","article-title":"Mineralocorticoid receptor signaling: crosstalk with membrane receptors and other modulators","volume":"91","author":"Meinel","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.kint.2025.07.037_bib79","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.00159.2001","article-title":"Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells","volume":"282","author":"Gekle","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.07.037_bib80","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","article-title":"Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells","volume":"109","author":"Mazak","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.07.037_bib81","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/me.2004-0469","article-title":"Human mineralocorticoid receptor expression renders cells responsive for nongenotropic aldosterone actions","volume":"19","author":"Grossmann","year":"2005","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.kint.2025.07.037_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsbmb.2007.03.043","article-title":"Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor\/EGFR trans-activation pathway in the M1 kidney CCD cell line","volume":"107","author":"McEneaney","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.kint.2025.07.037_bib83","doi-asserted-by":"crossref","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","article-title":"Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation","volume":"296","author":"Huang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.07.037_bib84","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bbamcr.2010.02.008","article-title":"Colocalization of mineralocorticoid and EGF receptor at the plasma membrane","volume":"1803","author":"Grossmann","year":"2010","journal-title":"Biochim Biophys Acta"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825007483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825007483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:32:23Z","timestamp":1779942743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825007483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0085253825007483"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.07.037","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.08.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}